Jobs / Novo Nordisk / Senior Scientist In vivo Pharmacology

Senior Scientist In vivo Pharmacology

Novo Nordisk
Måløv, Capital Region of Denmark, DK Onsite Research
Apply for this position

About this role

   

Obesity Pharmacology

Måløv, Denmark

 

Are you passionate about in vivo pharmacology and eager to drive innovative drug discovery within obesity and cardiometabolic diseases? Do you thrive in a collaborative research environment where scientific excellence, curiosity, and patient impact go hand in hand? If so, this could be your opportunity to join Novo Nordisk and contribute to the development of tomorrow’s life-changing therapies.

 

Your New Role

As a Senior Scientist within In Vivo Pharmacology, you will play a pivotal role in advancing drug discovery projects from target ideation and validation through to candidate selection. You will act as a scientific expert within obesity research, collaborating across disciplines to deliver robust pharmacology data that supports decision-making and project progression.

 

Your responsibilities will include:

  • Leading scientific activities within obesity research, target discovery, innovation, and project progression.
  • Designing and conducting key internal and external experiments to validate human relevance and explore pharmacokinetics, pharmacodynamics, and mode of action.
  • Developing and implementing new in vivo and ex vivo models, methods, and technologies to assess biological activity of new targets.
  • Managing protocol writing, data analysis, interpretation, record keeping, reporting, and communication of results.
  • Communicating complex multidisciplinary topics to relevant stakeholders, including development, regulatory, safety, research leadership, project teams, and governance bodies.
  • Collaborating with internal stakeholders in a matrix environment, as well as external scientific advisors and academic centres of expertise.

 

You will have significant influence on project direction within your area of expertise while working with a high degree of independence. This role offers a unique opportunity to contribute directly to the discovery of new medicines that have the potential to improve the lives of millions of people living with serious chronic diseases.

 

Your New Department

You will join Obesity & Cardiometabolic Research within Global Research at Novo Nordisk. The department is dedicated to identifying and advancing innovative therapeutic approaches that address obesity and related chronic diseases.

 

Working closely with in vitro scientists and cross-functional research teams, the department establishes, validates, and applies advanced in vivo models across rodents and large animal models. Through a combination of internal expertise and external collaborations, the team delivers critical pharmacology insights that enable the progression of promising drug candidates into clinical development.

 

This is an environment where scientific excellence, collaboration, and innovation are highly valued, and where every team member contributes to advancing research that can have a meaningful impact on patient health.

 

Your Skills and Qualifications

We are looking for a highly motivated scientist with a strong scientific foundation and a passion for translational drug discovery.

 

To succeed in this role, you should have:

  • A MSc or PhD in a relevant life science discipline, with solid experience from academia, biotechnology, pharmaceutical research, or a related industry environment.
  • Strong scientific expertise within obesity, metabolism, physiology, pharmacology, or cardiometabolic disease research.
  • Demonstrated experience designing, conducting, and interpreting in vivo pharmacology studies, ideally involving rodent and/or large animal models.
  • Proven ability to communicate complex scientific concepts to diverse stakeholders and contribute effectively within cross-functional project teams.
  • Excellent collaboration, problem-solving, and stakeholder engagement skills, combined with fluency in written and spoken English.
  • Experience supporting the progression of drug discovery candidates towards clinical development, as well as international collaboration experience, will be considered advantageous.
  • Authorization to perform animal experiments, such as FELASA-accredited or equivalent certification.

 

Working at Novo Nordisk

Every day we seek the solutions that defeat serious chronic diseases. To do this, we approach our work with determination, constant curiosity and a commitment to finding better ways forward. For over 100 years, this dedication has driven us to build a company focused on lasting change for long-term health. One where diverse thinking, shared purpose and mutual respect come together to create extraordinary results. When you join us, you're not just starting a job – you're becoming part of a story that spans generations.

 

What we offer

At Novo Nordisk, you’ll join a global healthcare company with a unique culture and strong results. We offer continuous learning, career development, and benefits tailored to your life and career stage.

 

Salary:  For this role, the Annual Base Salary ranges from 651,000.00 to 956,900.00 DKK, corresponding to the level of the position.

 

The placement within the salary range will be assessed during the recruitment process based on the candidate’s skills, competencies, knowledge, and relevant experience.

 

Incentives and Benefits: The salary pa

About Novo Nordisk

Global leader in diabetes care, obesity, and rare disease treatments using biologic therapies. Headquartered in Bagsvaerd, Denmark.

novonordisk.com

Get jobs like this weekly
One email a week with fresh biotech roles. Unsubscribe in one click.
Job Details
LocationMåløv, Capital Region of Denmark, DK
Work typeOnsite
DepartmentResearch
SenioritySenior
Salary651,000 – 956,900 DKK / year
CountryDenmark
About the company
Novo Nordisk
Global leader in diabetes care, obesity, and rare disease treatments using biologic therapies. Headquartered in Bagsvaerd, Denmark.
View all 419 open jobs at Novo Nordisk
BioHired Insights
Hiring locations: United States (138), Denmark (82), China (34)
⚠ Layoff history
2 layoff events reported at Novo Nordisk:
  • Apr 2026 · 400 affected
  • Sep 2025 · 9000 affected · Global (~5,000 in Denmark)
See full layoff tracker →